Are there gender differences in starting protease inhibitors, HAART, and disease progression despite equal access to care?
about
Women-specific HIV/AIDS services: identifying and defining the components of holistic service delivery for women living with HIV/AIDSUse of highly active antiretroviral therapy in a cohort of HIV-seropositive womenDrug use and receipt of highly active antiretroviral therapy among HIV-infected persons in two U.S. clinic cohortsGender differences in clinical outcomes among HIV-positive individuals on antiretroviral therapy in Canada: a multisite cohort studyFactors associated with improvement in disability-adjusted life years in patients with HIV/AIDS.Sex differences in HIV outcomes in the highly active antiretroviral therapy era: a systematic reviewFemale gender predicts lower access and adherence to antiretroviral therapy in a setting of free healthcareHIV among Haitian-born persons in the United States, 1985-2007.Gender-based differences in treatment and outcome among HIV patients in South IndiaImpact of gender on response to highly active antiretroviral therapy in HIV-1 infected patients: a nationwide population-based cohort study.Comparative gender analysis of the efficacy and safety of atazanavir/ritonavir and lopinavir/ritonavir at 96 weeks in the CASTLE studyGender differences in HIV disease progression and treatment outcomes among HIV patients one year after starting antiretroviral treatment (ART) in Dar es Salaam, Tanzania.Relationship of gender, depression, and health care delivery with antiretroviral adherence in HIV-infected drug users.Physician and patient factors associated with ordering a colon evaluation after a positive fecal occult blood testPredictors of medication adherence among HIV-positive women in North America.Influence of gender on receipt of guideline-based antiretroviral therapy in the era of HAARTImpact of Early Initiation of Antiretroviral Therapy in Patients with Acute HIV Infection in Vienna, Austria.Prevalence of drug resistance and associated mutations in a population of Hiv-1+ Puerto Ricans in 2005.HIV providers' perceptions of and attitudes toward female versus male patientsGender differences in mortality and CD4 count response among virally suppressed HIV-positive patients.Sex differences in HIV-1-mediated immunopathology.Gender differences in non-adherence among Brazilian patients initiating antiretroviral therapy.Socio-economic- and sex-related disparities in rates of hospital admission among patients with HIV infection in Ontario: a population-based study.Evaluation of the adverse reactions of antiretroviral drug regimens in a tertiary care hospitalSex disparities in overall burden of disease among HIV-infected individuals in the Veterans Affairs healthcare systemStrategies for gender-equitable HIV services in rural India.Women facing HIV. Key question on women with HIV infection: Italian consensus workshop.Gender differences in discontinuation of antiretroviral treatment regimens.Hospitalization rates of people living with HIV in the United States, 2009.Gender inequalities in the response to combination antiretroviral therapy over time: the Swiss HIV Cohort Study.Effect of gender and calendar year on time to and duration of virologic suppression among antiretroviral-naïve HIV-infected individuals initiating combination antiretroviral therapy.Are there differences in disease progression and mortality among male and female HIV patients on antiretroviral therapy? A meta-analysis of observational cohorts.Suboptimal use of HIV drug resistance testing in a universal health-care setting.Predictive factors for immunological and virological endpoints in Thai patients receiving combination antiretroviral treatment.CD4 cell count and initiation of antiretroviral therapy: trends in seven UK centres, 1997?2003
P2860
Q26851185-EC2E64B8-8D5C-45C5-8082-91E80C7649D6Q28344328-F9EFB600-ADAC-4627-B98D-AFB2374AA7E4Q28477883-AF81529C-E7E5-4B4E-BF93-279500C85464Q28538221-C9CDF3CA-8620-4FD7-8304-0F52C1C52795Q30849449-E11BBAB5-2CBE-451A-BDAA-71A4DFB26354Q33566578-6A07250B-0AB6-4789-9989-4031861EB498Q33863309-16918B64-A649-4BAC-B206-A5EC7737991CQ34054869-456C9291-4958-4565-AF33-9BD6E0526C36Q34156789-DAB4C77C-490A-4EFA-9506-5CD38CB86CC6Q34472398-6827DDC4-59D4-47CC-8C75-D907BC5EFEEBQ34481365-0DF489F7-8756-4DAA-82C7-AD97AA11E95CQ34548610-8CFC0F01-4558-48C9-834C-828CAFC132DEQ34741365-1CC0D3A1-6451-4809-B084-1DB72BB6B02DQ34741635-D5EEE628-B35D-4244-BE98-2CED1BEFDC1DQ35536845-31C6E036-3F08-4F6D-BEF7-CBD1D1A2CC83Q35569290-188830A4-FFCF-42F0-ABC6-2A367C635F74Q35985891-2BDE95FC-0E1C-4636-8253-BE9CA4B5B7F4Q36016153-2F833B27-A5E8-45DB-BC3B-85758505B81FQ36291793-6288A462-E15D-4C17-AD4C-879615A1A4CDQ36629441-9EFC89CE-6EC4-4EB3-A6F7-006B654CECF4Q36764788-7B3E23C6-42EE-4728-9F34-5B1DBC1D62DBQ36844848-91E47357-F6A8-4CCA-9456-B195F6DF059BQ36845581-5BC29D4E-1BAE-42F3-998E-8BDAD411B3D7Q36865445-48B4DF5F-69BB-461B-AA04-CC2D0F523233Q36962380-A50E0A04-D43D-4E87-82AB-159D22995990Q37305745-C0341368-401B-4CC1-A4F1-3E851F63B2B1Q37421318-E6FA6D4E-96EB-440B-AB97-181ED48A106FQ37440855-58C14452-DF71-4DC3-BB95-AC2878428910Q37525293-FD99F9DB-D8A6-49F7-BF37-786696B0B7F9Q38418210-92E20966-3335-4A19-8B72-2FAB96038444Q38440869-C720C9A8-47CB-4182-850C-30C3D42CBE6CQ40860723-C8BDEEDF-C120-4F30-AD85-009994CF0B5DQ42685780-2C36E487-903A-401B-ADB5-E7232B490E0AQ50704853-3BC08A87-B318-4142-83E1-CFC909F58E19Q57180219-95EAC354-6121-4597-95D9-495D5FBF4C3F
P2860
Are there gender differences in starting protease inhibitors, HAART, and disease progression despite equal access to care?
description
2000 nî lūn-bûn
@nan
2000年の論文
@ja
2000年論文
@yue
2000年論文
@zh-hant
2000年論文
@zh-hk
2000年論文
@zh-mo
2000年論文
@zh-tw
2000年论文
@wuu
2000年论文
@zh
2000年论文
@zh-cn
name
Are there gender differences i ...... despite equal access to care?
@en
type
label
Are there gender differences i ...... despite equal access to care?
@en
prefLabel
Are there gender differences i ...... despite equal access to care?
@en
P2093
P1476
Are there gender differences i ...... despite equal access to care?
@en
P2093
P304
P356
10.1097/00126334-200008150-00013
P407
P577
2000-08-01T00:00:00Z